- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Impact of Cost on Patients' Access to Treatment
Zachary T. Bloomgarden, MD, MACE: We have to have rational drug pricing. We have to change, in such a fashion, to have the cost of drugs in America not differ from the cost of drugs in the United Kingdom, France, Germany, China, or Japan, for that matter. We need to have an effective approach to making drugs available for everyone.
Currently, individuals who have Medicare Part D have a huge burden of paying for drugs once they reach the so-called donut hole, and that certainly needs to change. But, most importantly, we have to stop confusing the cost of the drug, in terms of buying the product, [with] the cost of the drug in terms of its likelihood of ultimately affording benefit to the individual in question.
This is an area in which I fear that we’ve erred tremendously. We allow higher-cost versus lower-cost drugs to be prescribed less frequently, even though the higher-cost drugs may truly be better. So, we have to rethink some of our concepts.
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
